Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 42% ± 16% | |
peripheral blood | 18 studies | 37% ± 11% | |
intestine | 11 studies | 36% ± 17% | |
kidney | 9 studies | 39% ± 13% | |
brain | 8 studies | 29% ± 8% | |
liver | 7 studies | 34% ± 17% | |
bone marrow | 5 studies | 31% ± 13% | |
eye | 5 studies | 27% ± 9% | |
lymph node | 5 studies | 38% ± 18% | |
pancreas | 4 studies | 56% ± 16% | |
placenta | 4 studies | 57% ± 25% | |
uterus | 4 studies | 58% ± 13% | |
breast | 4 studies | 41% ± 4% | |
adrenal gland | 3 studies | 26% ± 6% | |
prostate | 3 studies | 26% ± 7% | |
adipose | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 5343.66 | 89 / 89 | 100% | 61.28 | 901 / 901 |
liver | 100% | 2810.31 | 226 / 226 | 100% | 49.78 | 406 / 406 |
ovary | 100% | 6425.30 | 180 / 180 | 100% | 61.38 | 430 / 430 |
pancreas | 100% | 3648.99 | 328 / 328 | 100% | 64.40 | 178 / 178 |
prostate | 100% | 4208.22 | 245 / 245 | 100% | 65.87 | 502 / 502 |
stomach | 100% | 3699.43 | 359 / 359 | 100% | 47.80 | 286 / 286 |
uterus | 100% | 5269.85 | 170 / 170 | 100% | 75.79 | 459 / 459 |
thymus | 100% | 5907.58 | 653 / 653 | 100% | 96.80 | 604 / 605 |
lung | 100% | 5467.60 | 578 / 578 | 100% | 66.80 | 1153 / 1155 |
breast | 100% | 6943.32 | 459 / 459 | 100% | 77.41 | 1116 / 1118 |
intestine | 100% | 4487.08 | 966 / 966 | 100% | 55.64 | 526 / 527 |
bladder | 100% | 5104.19 | 21 / 21 | 100% | 65.58 | 503 / 504 |
skin | 100% | 5418.90 | 1809 / 1809 | 100% | 82.24 | 471 / 472 |
esophagus | 100% | 3763.63 | 1445 / 1445 | 99% | 41.05 | 182 / 183 |
adrenal gland | 100% | 6452.95 | 258 / 258 | 99% | 58.12 | 227 / 230 |
brain | 97% | 1800.38 | 2568 / 2642 | 100% | 57.55 | 704 / 705 |
adipose | 100% | 7376.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5371.48 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 58.56 | 29 / 29 |
muscle | 100% | 4359.75 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4198.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.53 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 74.32 | 79 / 80 |
heart | 98% | 2937.81 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 3177.62 | 870 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006465 | Biological process | signal peptide processing |
GO_0009615 | Biological process | response to virus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005787 | Cellular component | signal peptidase complex |
GO_0008233 | Molecular function | peptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | SEC11A |
Protein name | Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18) Signal peptidase complex catalytic subunit SEC11 (EC 3.4.21.89) Signal peptidase complex catalytic subunit SEC11 (Signal peptidase complex catalytic subunit sec11) Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18) |
Synonyms | SPCS4A SPC18 SEC11L1 |
Description | FUNCTION: Catalytic component of the signal peptidase complex (SPC) which catalyzes the cleavage of N-terminal signal sequences from nascent proteins as they are translocated into the lumen of the endoplasmic reticulum . Specifically cleaves N-terminal signal peptides that contain a hydrophobic alpha-helix (h-region) shorter than 18-20 amino acids . . |
Accessions | ENST00000455959.7 [P67812-2] ENST00000560409.5 H0YNG3 H0YNX5 H0YKT4 P67812 ENST00000560266.5 [P67812-4] ENST00000268220.12 [P67812-1] ENST00000558196.1 ENST00000558134.5 [P67812-3] ENST00000558217.5 H0YNA5 ENST00000559729.5 |